These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8989778)

  • 21. Comparison of false negative rates between 100% rapid review and 10% random full rescreening as internal quality control methods in cervical cytology screening.
    Lee BC; Lam SY; Walker T
    Acta Cytol; 2009; 53(3):271-6. PubMed ID: 19534266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Automated screening for quality control using PAPNET: a study of 638 negative Pap smears.
    Keyhani-Rofagha S; Palma T; O'Toole RV
    Diagn Cytopathol; 1996 Jun; 14(4):316-20. PubMed ID: 8725131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Health technology assessment report: Computer-assisted Pap test for cervical cancer screening].
    Della Palma P; Moresco L; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(5 Suppl 3):e1-43. PubMed ID: 23139174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance of 3 methods for quality control for gynecologic cytology diagnoses.
    Utagawa ML; Shirata NK; Mattosinho de Castro Ferraz Mda G; di Loreto C; Dall' Agnol M; Longatto-Filho A
    Acta Cytol; 2008; 52(4):439-44. PubMed ID: 18702361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. HPV Effectiveness in Lowgrade Paps (HELP) Study No. 1 Group.
    Lytwyn A; Sellors JW; Mahony JB; Daya D; Chapman W; Ellis N; Roth P; Lorincz AT; Gafni A
    CMAJ; 2000 Sep; 163(6):701-7. PubMed ID: 11022584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased detection of epithelial cell abnormalities by liquid-based gynecologic cytology preparations. A review of accumulated data.
    Austin RM; Ramzy I
    Acta Cytol; 1998; 42(1):178-84. PubMed ID: 9479337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PAPNET testing for HSILs. The few cell/small cell challenge.
    Solomon HM; Frist S
    Acta Cytol; 1998; 42(1):253-9. PubMed ID: 9479348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality control of cervical cytology in high-risk women. PAPNET system compared with manual rescreening.
    Bergeron C; Masseroli M; Ghezi A; Lemarie A; Mango L; Koss LG
    Acta Cytol; 2000; 44(2):151-7. PubMed ID: 10740599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automated Papanicolaou smear analysis as a screening tool for female lower genital tract malignancies.
    Ku NN
    Curr Opin Obstet Gynecol; 1999 Feb; 11(1):41-3. PubMed ID: 10047962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An evaluation of 'rapid review' as a method of quality control of cervical smears using the AxioHOME microscope.
    Baker RW; Wadsworth J; Brugal G; Coleman DV
    Cytopathology; 1997 Apr; 8(2):85-95. PubMed ID: 9134333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of false-negative Papanicolaou smears by rapid rescreening in a large routine cervical cytology laboratory.
    Wright RG; Halford JA; Ditchmen EJ
    Pathology; 1999 Nov; 31(4):379-81. PubMed ID: 10643010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. False negatives in focused rescreening of Papanicolaou smears: how frequently are 'abnormal' cells detected in retrospective review of smears preceding cancer or high-grade intraepithelial neoplasia?
    Wilbur DC
    Arch Pathol Lab Med; 1997 Mar; 121(3):273-6. PubMed ID: 9111117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Observer variation in cytologic grading for cervical dysplasia of Papanicolaou smears with the PAPNET testing system.
    Doornewaard H; van der Schouw YT; van der Graaf Y; Bos AB; van den Tweel JG
    Cancer; 1999 Aug; 87(4):178-83. PubMed ID: 10455204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Ki-67 antigen staining in Papanicolaou (pap) smears in postmenopausal women with atypia--an audit.
    Smedts F
    Cytopathology; 2001 Apr; 12(2):130-2. PubMed ID: 11284959
    [No Abstract]   [Full Text] [Related]  

  • 35. Prospective study of PAPNET: review of 25,656 Pap smears negative on manual screening and rapid rescreening.
    Halford JA; Wright RG; Ditchmen EJ
    Cytopathology; 1999 Oct; 10(5):317-23. PubMed ID: 10588350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative risk of high grade squamous intraepithelial lesion associated with prior abnormal Pap smears.
    Collins LC; Niloff J; Burke L; Abu-Jawdeh G; Wang H
    J Reprod Med; 2001 Feb; 46(2):105-9. PubMed ID: 11255808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Searching for an ideal cervical cancer screening model to reduce false-negative errors in a country with high prevalence of cervical cancer.
    Song T; Seong SJ; Lee SK; Kim BR; Ju W; Kim KH; Nam K; Sim JC; Kim TJ
    J Obstet Gynaecol; 2020 Feb; 40(2):240-246. PubMed ID: 31340702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Internal quality assurance in cervical cytology one laboratory's experience.
    Cross PA
    Cytopathology; 1996 Feb; 7(1):25-31. PubMed ID: 8833871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do proficiency test results correlate with the work performance of screeners who screen Papanicolaou smears?
    Keenlyside RA; Collins CL; Hancock JS; Gagnon MC; Cohn RD; Menoff AL; Dodd LG; Kurtycz DF; Hearn TL; Baker EL
    Am J Clin Pathol; 1999 Dec; 112(6):769-76. PubMed ID: 10587699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of a control quality strategy in cervical cytology.
    Gullo CE; Dami AL; Barbosa AP; Marques AM; Palmejani MA; de Lima LG; Bonilha JL
    Einstein (Sao Paulo); 2012; 10(1):86-91. PubMed ID: 23045833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.